{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:34:01Z","timestamp":1788924841193,"version":"build-2803163510"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009283","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:45:18Z","timestamp":1513172718000},"page":"e9283","source":"Crossref","is-referenced-by-count":30,"title":["Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis"],"prefix":"10.1097","volume":"96","author":[{"given":"Christian","family":"Nusshag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Morath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-136-20210226","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","article-title":"Hemophagocytic syndromes\u2014an update","volume":"28","author":"Janka","year":"2014","journal-title":"Blood Rev"},{"key":"R2-136-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.03.023","article-title":"Similar but not the same: differential diagnosis of HLH and sepsis","volume":"114","author":"Machowicz","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R3-136-20210226","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R4-136-20210226","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/ndt\/gfp282","article-title":"Haemophagocytic syndrome\u2014a life-threatening complication of renal transplantation","volume":"24","author":"Ponticelli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R5-136-20210226","first-page":"1414","article-title":"Haemophagocytic syndrome in rheumatic patients. A systematic review","volume":"16","author":"Atteritano","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R6-136-20210226","first-page":"29","article-title":"Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society","volume":"18","author":"Henter","year":"1991","journal-title":"Semin Oncol"},{"key":"R7-136-20210226","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","article-title":"Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatrica"},{"key":"R8-136-20210226","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R9-136-20210226","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/08880010390203891","article-title":"Primary hemophagocytic lymphohistiocytosis in Turkish children","volume":"20","author":"G\u00fcrgey","year":"2003","journal-title":"Pediatric Hematology and Oncology"},{"key":"R10-136-20210226","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/10428194.2010.551153","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center","volume":"52","author":"Machaczka","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R11-136-20210226","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"R12-136-20210226","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00043426-200210000-00011","article-title":"Adverse outcomes in primary hemophagocytic lymphohistiocytosis","volume":"24","author":"Sung","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R13-136-20210226","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PCC.0b013e318198868b","article-title":"An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis","volume":"10","author":"Karapinar","year":"2009","journal-title":"PediatrCritic Care Med"},{"key":"R14-136-20210226","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R15-136-20210226","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1002\/art.34661","article-title":"Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis","volume":"64","author":"Bennett","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R16-136-20210226","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","article-title":"Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients","volume":"40","author":"St\u00e9phan","year":"2001","journal-title":"Rheumatology (Oxford"},{"key":"R17-136-20210226","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"key":"R18-136-20210226","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"R19-136-20210226","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jaci.2012.01.053","article-title":"CD27: a new player in the field of common variable immunodeficiency and EBV-associated lymphoproliferative disorder?","volume":"129","author":"Seidel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R20-136-20210226","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1182\/blood-2010-08-302943","article-title":"Platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)","volume":"116","author":"Sandrock","year":"2010","journal-title":"Blood"},{"key":"R21-136-20210226","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI37901","article-title":"Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J Clin Invest"},{"key":"R22-136-20210226","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2016.10.023","article-title":"Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis","volume":"64","author":"Ramachandran","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"R24-136-20210226","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc11256","article-title":"Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: what is the treatment?","volume":"16","author":"Demirkol","year":"2012","journal-title":"Crit Care"},{"key":"R25-136-20210226","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"R26-136-20210226","doi-asserted-by":"crossref","first-page":"e6656","DOI":"10.1097\/MD.0000000000006656","article-title":"Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: a case report treated with high doses (8 mg\/kg\/d) of anakinra","volume":"96","author":"Parisi","year":"2017","journal-title":"Medicine"},{"key":"R27-136-20210226","first-page":"885066617711386","article-title":"Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically Ill adult patients with hemophagocytic lymphohistiocytosis.","volume":"15","author":"Wohlfarth","year":"2017","journal-title":"J Int Care Med"},{"key":"R28-136-20210226","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0889-8588(05)70521-9","article-title":"Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis","volume":"12","author":"Janka","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"R29-136-20210226","first-page":"230","article-title":"Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation","volume":"132","author":"Emmenegger","year":"2002","journal-title":"Swiss Med Wkly"},{"key":"R30-136-20210226","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu Rev Med"},{"key":"R31-136-20210226","first-page":"459","article-title":"The incidence of macrophage activation syndrome in children with rheumatic disorders","volume":"63","author":"Moradinejad","year":"2011","journal-title":"Minerva Pediatr"},{"key":"R32-136-20210226","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborat","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R33-136-20210226","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis","volume":"28","author":"Henter","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"R34-136-20210226","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"key":"R35-136-20210226","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R36-136-20210226","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/cncr.30084","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes","volume":"122","author":"Tamamyan","year":"2016","journal-title":"Cancer"},{"key":"R37-136-20210226","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/ijms18071387","article-title":"Issues of acute kidney injury staging and management in sepsis and critical illness: a narrative review","volume":"18","author":"Nusshag","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R38-136-20210226","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","article-title":"A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes","volume":"119","author":"Bryceson","year":"2012","journal-title":"Blood"},{"key":"R39-136-20210226","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/QAD.0b013e328339e55b","article-title":"Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis","volume":"24","author":"Fardet","year":"2010","journal-title":"AIDS"},{"key":"R40-136-20210226","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.TP.0000107285.86939.37","article-title":"Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature","volume":"77","author":"Karras","year":"2004","journal-title":"Transplantation"},{"key":"R41-136-20210226","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bmt.1703554","article-title":"Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation","volume":"29","author":"Abe","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R42-136-20210226","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/1097-0142(197909)44:3<993::AID-CNCR2820440329>3.0.CO;2-5","article-title":"Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis","volume":"44","author":"Risdall","year":"1979","journal-title":"Cancer"},{"key":"R43-136-20210226","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2875-7-13","article-title":"Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population","volume":"7","author":"Sinha","year":"2008","journal-title":"Malaria J"},{"key":"R44-136-20210226","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1611::AID-IMMU1611>3.0.CO;2-6","article-title":"IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation","volume":"28","author":"Poggi","year":"1998","journal-title":"Eur J Immunol"},{"key":"R45-136-20210226","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"key":"R46-136-20210226","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"Fall","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R47-136-20210226","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"R49-136-20210226","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2007.06922.x","article-title":"Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis","volume":"140","author":"Horne","year":"2008","journal-title":"Br J Haematol"},{"key":"R50-136-20210226","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/pbc.22239","article-title":"Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis","volume":"54","author":"Yang","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R51-136-20210226","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.0b013e31824f800a","article-title":"CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis","volume":"78","author":"Deiva","year":"2012","journal-title":"Neurology"},{"key":"R52-136-20210226","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00277-017-3035-5","article-title":"Central nervous system involvement in adults with haemophagocytic lymphohistiocytosis: a single-center study","volume":"96","author":"Cai","year":"2017","journal-title":"Ann Hematol"},{"key":"R53-136-20210226","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/pbc.23405","article-title":"Neuroradiologic findings and follow-up with magnetic resonance imaging of the genetic forms of haemophagocytic lymphohistiocytosis with CNS involvement","volume":"58","author":"Rego","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R54-136-20210226","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/pbc.25058","article-title":"Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis","volume":"61","author":"Lehmberg","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R55-136-20210226","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","article-title":"Marked hyperferritinemia does not predict for HLH in the adult population","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"key":"R56-136-20210226","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2014.10.012","article-title":"Acute kidney injury in adults with hemophagocytic lymphohistiocytosis","volume":"65","author":"Aulagnon","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R57-136-20210226","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12959-016-0117-x","article-title":"Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis","volume":"14","author":"Asakura","year":"2016","journal-title":"Thromb J"},{"key":"R58-136-20210226","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"R59-136-20210226","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J Exp Med"},{"key":"R60-136-20210226","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2141.2003.04726.x","article-title":"Modern management of children with haemophagocytic lymphohistiocytosis","volume":"124","author":"Janka","year":"2004","journal-title":"Br J Haematol"},{"key":"R61-136-20210226","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2009.02.005","article-title":"Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin","volume":"132","author":"Coca","year":"2009","journal-title":"Clin Immunol"},{"key":"R62-136-20210226","first-page":"92","article-title":"Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review","volume":"15","author":"Lin","year":"2017","journal-title":"Ann Hematol"},{"key":"R63-136-20210226","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pbc.22037","article-title":"Infection of T lymphocytes in Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin","volume":"53","author":"Beutel","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R64-136-20210226","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/bjh.12386","article-title":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens","volume":"162","author":"Chellapandian","year":"2013","journal-title":"Br J Haematol"},{"key":"R65-136-20210226","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPH.0b013e3181923cb4","article-title":"Experience with hemophagocytic lymphohistiocytosis\/macrophage activation syndrome at a single institution","volume":"31","author":"Gupta","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R66-136-20210226","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1744-9987.2009.00607.x","article-title":"A case report of successful treatment with plasma exchange for hemophagocytic syndrome associated with severe systemic juvenile idiopathic arthritis in an infant girl","volume":"13","author":"Nakakura","year":"2009","journal-title":"Ther Apher Dial"},{"key":"R67-136-20210226","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1744-9987.2006.00347.x","article-title":"Effect of plasma exchange on the circulating IL-6 levels in a patient with fatal hemophagocytic syndrome associated with bile ductopenia","volume":"10","author":"Song","year":"2006","journal-title":"Ther Apher Dial"},{"key":"R68-136-20210226","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V60.4.814.814","article-title":"Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis","volume":"60","author":"Ladisch","year":"1982","journal-title":"Blood"},{"key":"R69-136-20210226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.transci.2016.09.015","article-title":"Therapeutic plasma exchange in primary hemophagocytic lymphohistiocytosis: reports of two cases and a review of the literature","volume":"55","author":"Bosnak","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"R70-136-20210226","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2177\/jsci.36.478","article-title":"Successful treatment of glucocorticoid and cyclosporine refractory adult-onset Still's disease complicated with hemophagocytic syndrome with plasma exchange therapy and tocilizumab: a case report","volume":"36","author":"Komiya","year":"2013","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"R71-136-20210226","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12185-012-1170-2","article-title":"Sequential monitoring of serum IL-6, TNF-\u03b1, and IFN-\u03b3 levels in a CAEBV patient treated by plasma exchange and immunochemotherapy","volume":"96","author":"Arai","year":"2012","journal-title":"Int J Hematol"},{"key":"R72-136-20210226","doi-asserted-by":"crossref","first-page":"e5431","DOI":"10.1097\/MD.0000000000005431","article-title":"Acute liver failure caused by hemophagocytic lymphohistiocytosis in adults: a case report and review of the literature","volume":"95","author":"Lin","year":"2016","journal-title":"Medicine"},{"key":"R73-136-20210226","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12883-015-0470-6","article-title":"Adult-onset central nervous system hemophagocytic lymphohistiocytosis: a case report","volume":"15","author":"Pastula","year":"2015","journal-title":"BMC Neurol"},{"key":"R74-136-20210226","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-017-1662-9","article-title":"Hemoadsorption by CytoSorb in septic patients: a case series","volume":"21","author":"Kogelmann","year":"2017","journal-title":"Crit Care"},{"key":"R75-136-20210226","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1073\/pnas.74.10.4624","article-title":"Human leukocytic pyrogen: purification and development of a radioimmunoassay","volume":"74","author":"Dinarello","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"R76-136-20210226","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R77-136-20210226","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R78-136-20210226","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R79-136-20210226","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adult-onset Still's disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R80-136-20210226","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/ncprheum0919","article-title":"A case of macrophage activation syndrome successfully treated with anakinra","volume":"4","author":"Kelly","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R81-136-20210226","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","article-title":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients","volume":"50","author":"Miettunen","year":"2011","journal-title":"Rheumatology (Oxford"},{"key":"R82-136-20210226","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3899\/jrheum.091046","article-title":"Macrophage activation syndrome treated with anakinra","volume":"37","author":"Durand","year":"2010","journal-title":"J Rheumatol"},{"key":"R83-136-20210226","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1309\/AJCPMD5TJEFOOVBW","article-title":"Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability","volume":"141","author":"Ho","year":"2014","journal-title":"Am J Clin Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:48:04Z","timestamp":1620960484000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712150-00136"}},"subtitle":["A case report and review of the literature"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":81,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009283","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}